Skip to main content
. 2014 Nov 11;76:104–109. doi: 10.1016/j.curtheres.2014.08.003

Table II.

Baseline demographic characteristics.

Characteristic Peak (n = 119)
Modified peak (n = 305)
Total Low-dose (n = 82) High-dose (n = 37) P Total Low-dose (n = 195) High-dose (n= 110) P
Male gender* 82 (68.9) 55 (67.1) 27 (73.0) 0.52 208 (68.2) 134 (68.7) 74 (67.3) 0.79
Age 65.2 (53.8–74.0) 64.5 (53.8–74.1) 68.2 (54.8–72.8) 0.91 63.6 (49.8–72.6) 64.6 (53.5–74.1) 60.7 (45.5–69.4) 0.0067
Race*
 White 102 (85.7) 71 (86.6) 31 (83.8) 0.6860 260 (85.2) 167 (85.6) 93 (84.5) 0.7956
 Hispanic 2 (1.7) 2 (2.4) 0 (0) 4 (1.3) 4 (2.1) 0 (0)
 African American 1 (0.8) 1 (1.2) 0 (0) 2 (0.7) 2 (1.0) 0 (0)
 Asian/Pacific Islander 0 (0) 0 (0) 0 (0) 2 (0.7) 0 (0) 2 (1.8)
 Native American 0 (0) 0 (0) 0 (0) 1 (0.3) 1 (0.5) 0 (0)
 Other/not reported 14 (11.8) 8 (9.8) 6 (16.2) 36 (11.8) 21 (10.8) 15 (13.6)
Weight (kg) 74.0 (63.3–85.8) 75.1 (65.8–87.7) 71.5 (60.4–79.8) 0.058 75.4 (63.4–88.1) 74.8 (64.6–90.0) 73.3 (61.1–84.5) 0.087
Body mass index 24.8 (21.5–27.9) 25.3 (22.0–29.7) 23.0 (20.3–25.1) 0.011 25.0 (21.9–29.2) 25.4 (22.7–30.1) 24.6 (21.5–27.9) 0.036
Creatinine clearance 68.4 (44.9–97.6) 65.3 (37.5–95.9) 78.5 (52.0–106.8) 0.065 69.8 (46.3–103.3) 64.1 (39.6–94.1) 78.0 (53.2–110.5) 0.001
Comorbidities
Chronic kidney disease* 25 (21.0) 17 (20.7) 8 (21.6) 0.91 62 (20.3) 42 (21.5) 20 (18.3) 0.48
Dialysis* 17 (14.3) 15 (18.3) 2 (5.4) 0.063 42 (13.8) 33 (16.9) 9 (8.2) 0.033
 Hemodialysis 11 (9.2) 11 (13.4) 0 (0) 27 (8.9) 22 (11.3) 5 (4.5)
 Continuous venovenous hemofiltration 6 (5.0) 4 (4.9) 2 (5.4) 15 (4.9) 11 (5.6) 4 (3.6)
Diabetes* 30 (25.2) 24 (29.3) 6 (16.2) 0.13 70 (23.0) 56 (28.7) 14 (12.7) 0.0014
Immunocompromised* 107 (89.9) 71 (86.6) 36 (97.3) 0.073 267 (87.5) 161 (82.6) 106 (96.4) 0.0005

Values are given as n (%).

Values are given as median (interquartile range).

Values are given as median (mL/min).